Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.
Major therapeutic progress has been accomplished in leukemia and myelodysplastic syndrome (MDS) over the past 40 years, which may not be fully appreciated by the larger medical community. The objective of this review was to briefly highlight the treatment breakthroughs in leukemia and MDS. Therapeutic progress happened through better understanding of disease pathophysiologies and rational development of targeted agents, like imatinib mesylate in chronic myeloid leukemia (CML), and through astute, empirical discoveries in the clinic, like all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia (APL) and chlorodeoxyadenosine in hairy cell leukemia (HCL). Today, the 5- to 10-year survival rates in patients with APL and HCL exceed 80%. In patients with CML, imatinib therapy has been associated with estimated 5- to 7-year survival rates from 85% to 90%. In patients with adult acute lymphocytic leukemia, modern intensive regimens have improved the 5-year survival rates from 20% up to 40%. In patients with chronic lymphocytic leukemia, chemoimmunotherapy recently produced high rates of quality responses and improved long-term outcome. In younger patients with acute myeloid leukemia (AML), the 5-year survival rates range from 40% to 50%, although elderly AML remains a therapeutic challenge. In patients with MDS, it was recently demonstrated that epigenetic therapy with hypomethylating agents improved survival. Much therapeutic progress has been witnessed in leukemia and MDS, and much more is expected to occur soon.
Kantarjian
Hagop
H
Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. hkantarj@mdanderson.org
O'Brien
Susan
S
Cortes
Jorge
J
Wierda
William
W
Faderl
Stefan
S
Garcia-Manero
Guillermo
G
Issa
Jean-Pierre
JP
Estey
Elihu
E
Keating
Michael
M
Freireich
Emil J
EJ
D006801:Humans; D007938:Leukemia / Q000401:mortality / Q000628:therapy*; D007943:Leukemia, Hairy Cell / Q000401:mortality / Q000628:therapy; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000401:mortality / Q000628:therapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000401:mortality / Q000628:therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000401:mortality / Q000628:therapy*
Blood. 2007 Jan 15;109(2):500-2
16990603
Blood. 2004 Sep 15;104(6):1624-30
15178574
Blood. 1999 Nov 1;94(9):3015-21
10556184
Br J Haematol. 2003 Dec;123(5):810-8
14632771
Blood. 2000 Jun 1;95(11):3310-22
10828010
J Clin Oncol. 2002 May 15;20(10):2429-40
12011120
Ann Intern Med. 1999 Aug 3;131(3):207-19
10428738
Blood. 2004 Oct 1;104(7):1995-9
15187030
Clin Cancer Res. 2007 Dec 1;13(23):7107-12
18056190
Blood. 1991 Apr 15;77(8):1666-74
2015395
J Clin Oncol. 2007 Sep 1;25(25):3908-14
17761974
N Engl J Med. 2000 Dec 14;343(24):1750-7
11114313
Blood. 1998 Aug 15;92(4):1165-71
9694704
N Engl J Med. 1995 Jan 26;332(4):217-23
7808487
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6649-53
2204061
Blood. 1995 Aug 15;86(4):1619-28
7632972
Blood. 2002 Dec 15;100(13):4298-302
12393590
J Clin Oncol. 2008 Jul 20;26(21):3607-13
18559873
J Clin Oncol. 2000 Apr;18(7):1508-16
10735899
J Clin Oncol. 2005 Aug 20;23(24):5705-17
16110030
J Clin Oncol. 2004 Feb 15;22(4):624-33
14726504
Blood. 1999 Sep 15;94(6):1840-7
10477712
N Engl J Med. 2006 Dec 7;355(23):2408-17
17151364
J Clin Oncol. 2005 May 20;23(15):3396-403
15908652
Cancer. 2006 Oct 1;107(7):1551-61
16955505
Blood. 2007 Feb 15;109(4):1408-13
17062730
J Clin Oncol. 2006 Feb 10;24(5):790-7
16418499
Blood. 2004 Apr 15;103(8):2873-8
15070658
Leukemia. 2004 Dec;18(12):2032-5
15483674
Blood. 2006 Sep 15;108(6):1835-40
16709931
J Clin Oncol. 2005 Jun 10;23(17):3948-56
15883410
Blood. 2001 Sep 1;98(5):1302-11
11520775
Blood. 2002 Sep 15;100(6):1997-2004
12200358
J Clin Oncol. 1995 Apr;13(4):974-82
7707126
J Clin Oncol. 2004 Mar 15;22(6):1087-94
15020610
Blood. 2007 Apr 15;109(8):3207-13
17185463
Blood. 2004 Jun 15;103(12):4396-407
14551133
Blood. 2003 May 15;101(10):3809-17
12531809
Blood. 2005 Dec 1;106(12):3733-9
16076867
N Engl J Med. 2003 Oct 9;349(15):1451-64
14534339
Blood. 2005 Aug 1;106(3):803-11
15840690
Blood. 2007 Jun 1;109(11):4679-85
17299097
N Engl J Med. 2000 Dec 28;343(26):1910-6
11136261
Hematol Oncol Clin North Am. 2000 Dec;14(6):1327-52
11147226
Cancer Res. 1998 Sep 15;58(18):4173-9
9751631
Cancer. 2003 Feb 15;97(4):1033-41
12569603
Blood. 1995 Sep 15;86(6):2091-7
7662956
J Clin Oncol. 2003 Mar 1;21(5):774-80
12610173
Ann Intern Med. 1995 Feb 15;122(4):254-61
7825760
N Engl J Med. 2004 Apr 15;350(16):1617-28
15084694
J Clin Oncol. 2002 Aug 1;20(15):3254-61
12149299
Blood. 2003 Jan 1;101(1):6-14
12393429
Blood. 2006 Sep 1;108(5):1478-84
16627756
J Clin Oncol. 1999 Dec;17(12):3835-49
10577857
Blood. 2001 Sep 15;98(6):1752-9
11535508
Science. 1990 Feb 16;247(4944):824-30
2406902
Blood. 2003 Jul 1;102(1):276-83
12623848
J Clin Oncol. 2003 Jan 15;21(2):179-81
12525506
Blood. 2008 Feb 15;111(4):1834-9
18048643
Blood. 2004 May 15;103(10):3669-76
14726387
Cancer. 2006 Apr 15;106(8):1794-803
16532500
Leuk Res. 2006 Dec;30(12):1591-5
16574225
J Clin Oncol. 2006 Jun 1;24(16):2465-71
16651646
Hematol Oncol Clin North Am. 2000 Dec;14(6):1353-66, x
11147227
J Natl Cancer Inst. 1997 Nov 5;89(21):1616-20
9362160
Cancer Cell. 2002 Mar;1(2):133-43
12086872
Blood. 1992 Mar 1;79(5):1111-20
1371410
Blood. 2005 Dec 1;106(12):3740-6
16051734
Blood. 2007 Mar 15;109(6):2303-9
17138817
J Clin Oncol. 2005 May 20;23(15):3376-82
15908649
Br J Haematol. 2002 Sep;118(3):748-54
12181041
Cancer Res. 1967 Dec;27(12):2573-7
5237353
Blood. 1991 Dec 1;78(11):2814-22
1835410
Blood. 2001 Sep 1;98(5):1312-20
11520776
Blood. 2007 May 15;109(10):4143-50
17264298
J Clin Oncol. 2006 Aug 20;24(24):3895-903
16921040
J Clin Oncol. 2005 Sep 10;23(26):6306-15
16155013
Blood. 1990 Jan 1;75(1):27-32
2403818
N Engl J Med. 1998 Jun 4;338(23):1663-71
9614257
Blood. 2002 May 15;99(10):3554-61
11986207
Blood. 2005 May 1;105(9):3434-41
15650057
Cancer. 2007 Mar 15;109(6):1133-7
17315156
Blood. 1995 Mar 15;85(6):1580-9
7888675
Cancer. 2006 Jul 1;107(1):116-24
16721819
Cancer. 2007 Apr 15;109(8):1556-60
17342766
Blood. 2007 Apr 1;109(7):2744-50
17132721
Blood. 1999 Jun 15;93(12):4116-24
10361108
Blood. 1996 Oct 15;88(8):2841-51
8874180
N Engl J Med. 2004 Aug 5;351(6):533-42
15295046
N Engl J Med. 1998 Dec 3;339(23):1649-56
9834301
Blood. 2008 Feb 15;111(4):1774-80
18055868
Blood. 2006 Feb 1;107(3):885-91
16219797
Blood. 2002 Feb 1;99(3):759-67
11806975
Cancer. 2003 Oct 1;98(7):1337-54
14508819
J Clin Oncol. 2006 Aug 20;24(24):3880-6
16864854
Br J Haematol. 2005 Jun;129(6):734-45
15952999
Cancer. 2006 Mar 1;106(5):1090-8
16435386
Blood. 2003 Jan 15;101(2):473-5
12393385
Blood. 2007 Jun 15;109(12):5143-50
17317857
Blood. 2007 Jan 1;109(1):52-7
16882708
Blood. 2002 Dec 15;100(13):4325-36
12393746
J Clin Oncol. 2008 Jul 1;26(19):3204-12
18541900
N Engl J Med. 2006 Jan 12;354(2):166-78
16407512
J Clin Oncol. 1994 Feb;12(2):262-7
8113835
Ann Intern Med. 1995 Sep 15;123(6):428-31
7639442
Blood. 2005 Jan 1;105(1):54-60
15345597
Blood. 1999 Jun 1;93(11):3983-93
10339508
Blood. 2002 Oct 15;100(8):2717-23
12351377
Blood. 2002 Mar 15;99(6):1986-94
11877270
Cancer. 2007 Oct 1;110(7):1509-19
17702093
Blood. 2005 Dec 1;106(12):3760-7
16105981
Cancer. 2004 Feb 1;100(3):441-54
14745859
Blood. 2000 Nov 1;96(9):2981-6
11049974
N Engl J Med. 2006 Oct 5;355(14):1456-65
17021321
Lancet. 1996 May 25;347(9013):1432-8
8676625
J Clin Oncol. 2005 Oct 1;23(28):7161-7
16192600
Lancet. 1969 Feb 15;1(7590):330-3
4179349
Cancer. 2007 Jun 1;109(11):2171-81
17431887
J Clin Oncol. 2001 Mar 1;19(5):1414-20
11230486
Blood. 1998 Oct 1;92(7):2322-33
9746770
Clin Cancer Res. 2001 Mar;7(3):709-23
11297268
Blood. 2003 Oct 15;102(8):3052-9
12842990
Cancer. 2007 Nov 1;110(9):1900-10
17786921
Exp Hematol. 2004 Jan;32(1):28-35
14725898
Br J Haematol. 2001 Sep;114(4):800-9
11564066
Cancer. 2007 Jan 15;109(2):265-73
17133405
Clin Cancer Res. 2005 May 1;11(9):3425-32
15867244
Blood. 2002 Sep 1;100(5):1532-42
12176867
Cancer. 2005 May 1;103(9):1850-5
15786422
N Engl J Med. 1994 Oct 6;331(14):896-903
8078551
J Clin Oncol. 2005 Jun 20;23(18):4070-8
15767647
J Clin Oncol. 2006 Jan 20;24(3):460-6
16344315
Cancer. 2006 Jun 15;106(12):2645-51
16688777
Blood. 2006 Apr 1;107(7):2627-32
16352810
N Engl J Med. 2003 Mar 13;348(11):994-1004
12637609
J Clin Oncol. 2007 Mar 1;25(7):793-8
17283364
Cancer. 2004 Jul 15;101(2):226-41
15241818
Blood. 2008 Jan 1;111(1):86-93
17893227
J Clin Oncol. 2003 Mar 1;21(5):891-6
12610190
N Engl J Med. 2003 May 1;348(18):1764-75
12724482
Blood. 1997 Oct 1;90(7):2843-6
9326255
Eur J Haematol. 2007 Jun;78(6):487-94
17391310
Blood. 2007 Apr 15;109(8):3214-8
17209054
Leukemia. 2007 Jul;21(7):1436-41
17507999
Blood. 2002 Mar 1;99(5):1536-43
11861265
Cancer. 2006 Jan 1;106(1):120-7
16331634
Blood. 1999 Apr 15;93(8):2478-84
10194425
J Clin Oncol. 2005 Jun 20;23(18):4079-88
15767648
J Clin Oncol. 2006 Dec 1;24(34):5343-9
17088571
Blood. 2006 May 1;107(9):3469-73
16373661
Cancer. 2005 May 15;103(10):1985-95
15803490
Blood. 2007 Aug 15;110(4):1233-7
17449798
Br J Haematol. 1982 Jun;51(2):189-99
6952920
Blood. 1992 Jan 15;79(2):313-9
1730080
Blood. 2004 Jul 15;104(2):579-85
15039286
Blood. 2001 Mar 1;97(5):1211-8
11222362
Hematol Oncol Clin North Am. 2000 Dec;14(6):1307-25, ix
11147225
Blood. 1996 Mar 1;87(5):1710-7
8634416
Cancer. 2006 Apr 1;106(7):1569-80
16502413
Hematol Oncol Clin North Am. 2000 Dec;14(6):1367-79, x
11147228
Cancer. 2001 Oct 15;92(8):1999-2015
11596013
Blood. 2006 Jul 1;108(1):28-37
16522812
Lancet. 2007 Jul 21;370(9583):230-239
17658394
Clin Cancer Res. 2007 Dec 1;13(23):7080-5
18056186
Blood. 2001 Jun 1;97(11):3370-9
11369626
Blood. 2007 Oct 15;110(8):2991-5
17625066
Blood. 2008 Feb 15;111(4):1827-33
18048644
Leukemia. 2006 Oct;20(10):1767-73
16855631
Blood. 2001 Oct 15;98(8):2319-25
11588025
N Engl J Med. 2004 Aug 26;351(9):893-901
15329427
Blood. 2007 Nov 15;110(10):3540-6
17715389
Cancer. 2007 Mar 15;109(6):1007-10
17279580
N Engl J Med. 2006 Jun 15;354(24):2531-41
16775234
Blood. 2003 Mar 1;101(5):1692-7
12411300
Cancer. 2006 Mar 1;106(5):1099-109
16435387
J Clin Oncol. 2005 Oct 20;23(30):7594-603
16186598
Leukemia. 2002 Nov;16(11):2190-6
12399961
N Engl J Med. 2004 Apr 15;350(16):1605-16
15084693
Cancer. 2007 Mar 15;109(6):1114-24
17315155
Blood. 2000 Dec 15;96(13):4075-83
11110676
Cancer. 2004 Dec 15;101(12):2788-801
15481055
Blood. 2007 Oct 1;110(7):2309-15
17496201
Clin Cancer Res. 2002 Jul;8(7):2177-87
12114418
Blood. 2007 Apr 15;109(8):3189-97
17170120
Nature. 2008 Jan 17;451(7176):335-9
18202658
Arch Intern Med. 2002 Jul 22;162(14):1597-603
12123403
Cancer Cell. 2005 Apr;7(4):375-86
15837626
Blood. 2006 Jun 15;107(12):4658-62
16497968
N Engl J Med. 2006 Jun 15;354(24):2542-51
16775235
Blood. 1997 Mar 15;89(6):2079-88
9058730
Mayo Clin Proc. 2006 Jul;81(7):973-88
16835977
Blood. 1999 Sep 15;94(6):1848-54
10477713
Blood. 2003 Oct 1;102(7):2702-3; author reply 2703-4
14504074
N Engl J Med. 2004 Apr 8;350(15):1535-48
15071128
Blood. 2007 Jan 1;109(1):58-60
16973963